Signup Crypto ETF Stocks News

The Best Warren Buffett Stocks to Buy With $1,000 Right Now

Warren Buffett-led Berkshire Hathaway owns many stocks in its huge $284 billion public equity portfolio. Investors are certainly familiar with some of its well-known holdings. They include consumer electronics leader Apple, and beverage giant Coca-Cola.However, neither of these businesses are ...

Source: www.fool.com
May 24, 2025 | 08:05:00
Category: News

Billionaire Philippe Laffont Just Sold Shares of Nvidia and 2 Other AI Powerhouses and Bought Shares of This Nvidia-Backed Company

The artificial intelligence ( AI ) boom has driven stock market gains over the past couple of years, but the momentum may be far from over. Not only do analysts predict an AI market of more than $2 trillion by the early 2030s, but current activity in the space supports that.

Source: www.fool.com
May 24, 2025 | 08:10:00
Category: News

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.

Source: www.fool.com
May 24, 2025 | 08:11:00
Category: News

Palo Alto Networks Stock Drops Despite Strong Guidance -- Is This a Buying Opportunity?

Share prices of Palo Alto Networks ( NASDAQ: PANW ) slipped earlier this week after the company reported its fiscal Q3 earnings results. While the results were strong and topped analyst expectations, the company failed to raise the top end of its full-year fiscal 2025 guidance for the first time ...

Source: www.fool.com
May 24, 2025 | 08:15:00
Category: News

Elon Musk Praises Google DeepMind's Veo 3 AI Video Model, Says 'It Is Awesome' - Alphabet ( NASDAQ:GOOG ) , Alphabet ( NASDAQ:GOOGL )

At its annual developer conference this week, Alphabet Inc.'s GOOG GOOGL Google unveiled Veo 3, the latest upgrade to its AI video generation tool developed by Google DeepMind.

Source: www.benzinga.com
May 24, 2025 | 08:15:23
Category: News

Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond

The Dow Jones Industrial Average is an iconic stock market index. It tracks the performance of 30 of the country's most prominent publicly traded companies. Its components do get changed over time as new leaders rise and old ones fade, but as a rule, those that earn and keep a place in the Dow ...

Source: www.fool.com
May 24, 2025 | 08:16:00
Category: News

Could Investing in These American-Made High Yielders Pay Dividends for Your Portfolio?

If you are looking for American-made dividend stocks, you can't do much better than buying U.S. utilities. Companies like NextEra Energy ( NYSE: NEE ) , Black Hills ( NYSE: BKH ) , and American Electric Power ( NASDAQ: AEP ) are built on regional and regulated U.S. monopolies.

Source: www.fool.com
May 24, 2025 | 08:24:00
Category: News

These 3 Artificial Intelligence ( AI ) Stocks Look Cheap Right Now

The artificial intelligence industry is booming, which makes it an attractive sector to invest in. But AI hype has pushed up stock prices for several tech companies and inflated their valuations in many cases.Fortunately, investors looking for AI bargains can still find some.

Source: www.fool.com
May 24, 2025 | 08:30:00
Category: News

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection ( ESH 2025 ) - Mineralys Therapeutics ( NASDAQ:MLYS )

- Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-world setting -

Source: www.benzinga.com
May 24, 2025 | 08:30:00
Category: General

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection ( ESH 2025 )

- Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-world setting ...

Source: www.globenewswire.com
May 24, 2025 | 08:30:00
Category: News

© Natavest 2025 - 2026